Lesch-Nyhan syndrome is a rare genetic disorder that directly affects the metabolism of DNA. A somewhat unexpected consequence of this is a range of symptoms that present in behaviour, the most notable of which are self-injurious, aggressive and impulsive behaviours. 

Treatments for the neuropsychiatric symptoms in Lesch-Nyhan syndrome include a combination of pharmacological and behavioural approaches. Medication options like antipsychotics, SSRIs and muscle relaxants, and behavioural strategies like protective equipment and structured support, can help in reducing self-injury and improving quality of life. 

In this article, we will break down all options and how they work, how they are used and what they can offer for the long-term management of Lesch-Nyhan syndrome. 

Introduction

To better understand the reasoning behind how the neuropsychiatric symptoms of Lesch-Nyhan syndrome are treated, we must have a comprehensive understanding of the disorder.  

Overview 

Lesch-Nyhan syndrome is an extremely rare genetic condition that results from a mutation in a specific gene (called HPRT1) that encodes the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRT). This enzyme is responsible for the recycling of DNA building blocks (purines), hence it is a major player in metabolic processes. The result of the mutation is a buildup of a waste chemical called uric acid and a possible dysfunction in dopamine signalling in the brain.¹ 

Genetic inheritance

Lesch-Nyhan syndrome is an X-linked disorder. This means that it is most commonly passed from mother to son and almost always affects males. 

Symptoms  

Even though Lesch-Nyhan syndrome is a disorder of an enzyme, it is associated with a plethora of different symptoms, ranging from physical health problems to severe psychiatric and cognitive deficiencies. 

The symptoms associated with Lesch-Nyhan syndrome are:²

• Compulsive self-injury, including:
  • Head banging 
  • Banging of the limbs
  • Self-biting 
  • Eye poking
• Causing injury to others
• Other neuropsychiatric symptoms like:
  • Aggression
  • Symptoms of anxiety and depression
  • Interpersonal difficulties
• Problems with muscle movement 
• Bladder stones
• Kidney problems
• Inflammatory arthritis (gout)
• Anaemia associated with vitamin B12 deficiency (megaloblastic anaemia)
• Learning disabilities
• Cognitive deficiencies like:
  • Short attention span
  • Poor memory
  • Difficulties making plans

It is important to know the extent of symptoms experienced in Lesch-Nyhan syndrome, as it currently has no cure and is managed symptomatically.  

Pharmacologic Interventions

The neuropsychiatric features of Lesch-Nyhan syndrome are treated on a case-by-case basis, as they can vary from patient to patient in both severity and presentation. Furthermore, due to the rarity of the disorder, there is minimal research pointing to the effectiveness of medicines for symptom management. 

Antipsychotics

Antipsychotic medications, contrary to the name, are not only used to treat psychosis. They work by altering the balance of certain messenger chemicals (neurotransmitters) in the brain. Antipsychotics can be used in cases of Lesch-Nyhan syndrome to reduce aggressive and impulsive behaviours, as well as anxiety. 

An example of an antipsychotic medication that has been tried on patients with Lesch-Nyhan syndrome is risperidone. It has been shown to reduce self-injury behaviour in a few patients.²

Side effects of risperidone include:

• Difficulty sleeping
• Headaches 
• Stomach issues like pain, nausea or vomiting 
• Changes in appetite
• Constipation or diarrhoea 

Benzodiazepines

Benzodiazepines are medications that slow down the functions of the nervous system. They increase the activity of inhibitory signalling in the brain by increasing the actions of a neurotransmitter called GABA. The result in the body is sedation, reduced anxiety, and muscle relaxation. This may be useful in the case of Lesch-Nyhan syndrome for the reduction of self-injury behaviours; however, no formal research has been conducted for this drug class. 

A downside to the use of benzodiazepines is that they should only be used in the short term, due to their addictive properties. 

SSRIs and mood stabilisers

Selective serotonin reuptake inhibitors (SSRIs) and mood stabilisers can help to manage impulsive behaviours and mood disturbances. SSRIs work by increasing the action of the neurotransmitter serotonin in the brain, thus improving mood. Mood stabilisers can have various mechanisms, but primarily work to balance brain signals, thereby preventing the brain from becoming overactive or hyperexcitable. 

Examples of SSRI medicines used in the management of Lesch-Nyhan syndrome are paroxetine and sertraline, which have shown some promise in decreasing self-injury behaviours in one patient.³ 

Side effects of SSRIs include:

• Being shaky, anxious or agitated
• Digestion issues - Like nausea, vomiting, indigestion, constipation or diarrhoea 
• Appetite loss 
• Sleeping problems 
• Headaches

Examples of mood stabilisers tried in the management of Lesch-Nyhan syndrome are the anticonvulsant (anti-seizure) drugs carbamazepine and gabapentin. These drugs have shown some promise in the cessation of self-injury behaviour.^2,4 

Side effects of carbamazepine include:

• Sedation
• Nausea and vomiting
• Headaches 
• Weight gain

The side effects of gabapentin are similar to those of carbamazepine. 

Botulinum toxin

Botulinum toxin (most commonly known as BOTOX) is a toxin that can be used to reduce muscle function in the areas most prone to self-injury, like the jaw. This is usually injected into the target muscle and can cause reduction of behaviours that cause harm to self and others.²

Targeting dopamine

It is hypothesised that dopamine signalling is affected by Lesch-Nyhan syndrome. Therefore, there have been some cases where drugs that increase the function of the dopamine system have been used to try to manage symptoms. These include:²

• Tetrabenazine - Has been shown to reduce rapid, repetitive movements
• Baclofen - Although it does not target dopamine directly, it is thought that baclofen can help to balance dopamine signalling It has been shown to reduce self-injury behaviours in Lesch-Nyhan syndrome
• Levodopa/Carbidopa - These drugs boost the amount of dopamine in the brain. There is limited evidence for the effectiveness of these drugs in Lesch-Nyhan syndrome

Behavioural interventions

Behavioural interventions for Lesch-Nyhan syndrome have been described as limited in terms of long-term outcomes and numbers.⁵ This type of intervention is often something decided by a multidisciplinary team and is different case by case. Below we will explore the main behavioural interventions used in Lesch-Nyhan syndrome. 

Protective equipment

One of the most common forms of conservative intervention in Lesch-Nyhan syndrome is the use of protective equipment. Examples of protective equipment include:⁶

• Mouthguards
• Lip bumpers
• Restraints of the hands
• Padded helmets

The use of protective equipment to prevent self injury or injury to others is a controversial type of therapy, however is often necessary and a last resort in the management of symptoms. 

Occupational and sensory therapy

There is limited evidence for the effectiveness of occupational and sensory therapies in Lesch-Nyhan syndrome. However, it may be a valuable tool to teach those with Lesch-Nyhan syndrome how to self-regulate without injuring themselves or others. 

Caregiver training

Medical professionals may provide families and caregivers with specific training on how to safely and compassionately manage the neuropsychiatric symptoms of Lesch-Nyhan syndrome. This can improve the quality of life for individuals with the disorder. 

Multidisciplinary approach to treatment

The most important aspect of managing Lesch-Nyhan syndrome is the emphasis on a multidisciplinary and holistic approach. The combination of pharmacological and behavioural approaches aims to optimise the short and long-term outcomes of the patient. 

Summary

Lesch-Nyhan syndrome is a rare, inherited metabolic disorder that presents as a complex combination of neurological, psychiatric and physical symptoms. The most notable of the neuropsychiatric symptoms are self-injurious behaviours like self-biting, eye poking and head banging. While there is no cure for the disorder, a range of pharmacological and behavioural strategies can help manage the neuropsychiatric symptoms. Medications such as antipsychotics, selective serotonin reuptake inhibitors, mood stabilisers and muscle relaxants have shown various levels of success in treating aggression, impulsivity and self-injury. Evidence is minimal due to the rarity of the disease. Behavioural interventions, such as protective equipment, caregiver training, and specific therapies, can provide meaningful support, especially when integrated into a multidisciplinary care plan. Ultimately, tailored treatment approaches combining medications with the psychosocial backing offer the best hope for improving quality of life in individuals with Lesch-Nyhan syndrome.